X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3833) 3833
Publication (500) 500
Book Review (23) 23
Book Chapter (16) 16
Book / eBook (13) 13
Government Document (8) 8
Conference Proceeding (6) 6
Dissertation (3) 3
Data Set (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2390) 2390
animals (2047) 2047
cytotoxins - pharmacology (1898) 1898
index medicus (1565) 1565
cytotoxins - chemistry (842) 842
mice (829) 829
cytotoxicity (722) 722
pharmacology & pharmacy (721) 721
cell line, tumor (689) 689
biochemistry & molecular biology (632) 632
cytotoxins - toxicity (564) 564
cell line (521) 521
cell survival - drug effects (519) 519
apoptosis (517) 517
antineoplastic agents - pharmacology (451) 451
chemistry, medicinal (446) 446
female (434) 434
cytotoxins - isolation & purification (430) 430
male (416) 416
rats (404) 404
dose-response relationship, drug (393) 393
cancer (389) 389
toxicology (379) 379
cells, cultured (375) 375
apoptosis - drug effects (362) 362
analysis (331) 331
cytotoxins - metabolism (319) 319
cytotoxins (310) 310
in-vitro (298) 298
toxicity (291) 291
cells (275) 275
oncology (271) 271
molecular structure (262) 262
cytotoxins - chemical synthesis (257) 257
cell proliferation - drug effects (251) 251
cell biology (241) 241
research article (241) 241
microbiology (236) 236
antineoplastic agents - chemistry (235) 235
immunology (233) 233
proteins (229) 229
structure-activity relationship (226) 226
tumor cells, cultured (221) 221
bacterial toxins - pharmacology (219) 219
cytotoxin (218) 218
hela cells (214) 214
expression (210) 210
drug screening assays, antitumor (194) 194
research (190) 190
plant extracts - pharmacology (189) 189
oxidative stress (185) 185
anti-bacterial agents - pharmacology (184) 184
article (181) 181
activation (177) 177
inhibition (165) 165
antineoplastic agents - chemical synthesis (158) 158
neoplasms - drug therapy (148) 148
molecular sequence data (147) 147
time factors (146) 146
cytotoxins - biosynthesis (145) 145
chemistry, multidisciplinary (144) 144
plant sciences (140) 140
infectious diseases (139) 139
amino acid sequence (137) 137
cricetinae (137) 137
infection (137) 137
protein (136) 136
inhibitory concentration 50 (135) 135
kinetics (130) 130
bacteria (129) 129
chemotherapy (126) 126
helicobacter pylori (126) 126
reactive oxygen species - metabolism (125) 125
derivatives (123) 123
plant extracts - chemistry (123) 123
medicine (122) 122
cell death (120) 120
health aspects (120) 120
antioxidants - pharmacology (119) 119
cytotoxins - therapeutic use (119) 119
medicine, research & experimental (115) 115
chemistry, organic (114) 114
in vitro techniques (113) 113
biotechnology & applied microbiology (112) 112
drugs (110) 110
microbial sensitivity tests (110) 110
vacuolating cytotoxin (110) 110
physiological aspects (108) 108
binding (105) 105
multidisciplinary sciences (105) 105
toxins (105) 105
cattle (104) 104
toxin (104) 104
rabbits (103) 103
cell death - drug effects (100) 100
cytotoxins - analysis (100) 100
cytotoxins - genetics (99) 99
escherichia-coli (99) 99
growth (99) 99
antioxidants (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3765) 3765
Russian (38) 38
Japanese (19) 19
Chinese (15) 15
French (6) 6
German (5) 5
Spanish (5) 5
Hungarian (3) 3
Ukrainian (3) 3
Italian (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunopharmacology and immunotoxicology, ISSN 0892-3973, 1987
Journal
Toxicology and Applied Pharmacology, ISSN 0041-008X, 08/2016, Volume 305, pp. 55 - 65
Journal Article
Journal Article
BioMed research international, ISSN 2314-6133, 2018, Volume 2018, pp. 1023490 - 9
The antibody-dependent cell-mediated cytotoxicity (ADCC) of the anti-CD20 monoclonal antibodies (mAbs) rituximab and obinutuzumab against the cell line Raji... 
PRECLINICAL ACTIVITY | MEDICINE, RESEARCH & EXPERIMENTAL | IN-VITRO | EFFICACY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | RITUXIMAB | IBRUTINIB | CHRONIC LYMPHOCYTIC-LEUKEMIA | THERAPEUTIC ANTIBODIES | KINASE INHIBITORS | MONOCLONAL-ANTIBODIES | GA101 | Leukocytes, Mononuclear - metabolism | Leukocytes, Mononuclear - drug effects | Purines - pharmacology | Antibodies, Monoclonal - pharmacology | Humans | Antigens, CD20 - metabolism | Pyrimidines - pharmacology | Receptors, Antigen, B-Cell - metabolism | Rituximab - pharmacology | B-Lymphocytes - drug effects | Cytotoxins - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Cell Line, Tumor | Benzamides - pharmacology | Killer Cells, Natural - drug effects | Protein Kinase Inhibitors - pharmacology | Antibody-Dependent Cell Cytotoxicity - drug effects | Pyrazines - pharmacology | Quinazolinones - pharmacology | Pyrazoles - pharmacology | Toxicity | Leukemia | Impairment | Effector cells | Cytotoxicity | Leukocytes (mononuclear) | B-cell receptor | Kinases | Peripheral blood mononuclear cells | Natural killer cells | Calcein | Genetic modification | Recombinant | Antibody-dependent cell-mediated cytotoxicity | Immunoglobulins | Chronic lymphatic leukemia | Comorbidity | Interference | Rituximab | Lactate dehydrogenase | T cell receptors | Bruton's tyrosine kinase | L-Lactate dehydrogenase | CD16 antigen | Inhibitors | Lymphocytes B | Cell lines | Monoclonal antibodies | CD20 antigen | Lymphomas | Lactic acid
Journal Article
Nature Biotechnology, ISSN 1087-0156, 08/2008, Volume 26, Issue 8, pp. 925 - 932
Journal Article
Oncology, ISSN 0030-2414, 11/2014, Volume 87, Issue 6, pp. 351 - 363
Journal Article
Journal Article
Blood, ISSN 0006-4971, 09/2007, Volume 110, Issue 5, pp. 1656 - 1663
Activation of the extracellular signal-regulated kinase1/2 (ERK1/2) signaling cascade mediates human multiple myeloma (MM) growth and survival triggered by... 
Stromal Cells - pathology | RANK Ligand | Phosphorylcholine - analogs & derivatives | Thalidomide - pharmacology | Boronic Acids - therapeutic use | Thalidomide - analogs & derivatives | Cytotoxins - pharmacology | Dexamethasone - pharmacology | Benzimidazoles - therapeutic use | Cell Survival - drug effects | MAP Kinase Kinase 1 - antagonists & inhibitors | Osteoclasts - pathology | Bortezomib | Bone Marrow Cells - pathology | MAP Kinase Kinase 1 - metabolism | MAP Kinase Kinase 2 - metabolism | Cell Adhesion - drug effects | Dexamethasone - therapeutic use | Mitogen-Activated Protein Kinase 3 - metabolism | Benzimidazoles - pharmacology | Ligands | Mice | Thalidomide - therapeutic use | Pyrazines - pharmacology | Mitogen-Activated Protein Kinase 1 - metabolism | Neoplasm Transplantation | Bone Marrow Cells - enzymology | Transplantation, Heterologous | Pyrazines - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Stromal Cells - enzymology | Phosphorylcholine - pharmacology | Tumor Cells, Cultured | Multiple Myeloma - enzymology | Cytotoxins - therapeutic use | Macrophage Colony-Stimulating Factor - metabolism | Mice, SCID | Xenograft Model Antitumor Assays | Multiple Myeloma - pathology | Animals | MAP Kinase Signaling System - drug effects | Interleukin-6 - pharmacology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Differentiation - drug effects | MAP Kinase Kinase 2 - antagonists & inhibitors | Cell Proliferation - drug effects | Osteoclasts - enzymology | Boronic Acids - pharmacology | Phosphorylcholine - therapeutic use | Neoplasia
Journal Article